RankingsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Stockholders' equity

ABBOTT LABORATORIESABT

Market cap
$221.4B
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Dec 31, 202447,901+23.37%
Dec 31, 202338,827+5.21%
Dec 31, 202236,905+2.45%
Dec 31, 202136,024+9.15%
Dec 31, 202033,003+5.44%
Dec 31, 201931,301+1.88%
Dec 31, 201830,722-1.21%
Dec 31, 201731,098+50.11%
Dec 31, 201620,717-2.86%
Dec 31, 201521,326-1.45%
Dec 31, 201421,639-14.36%
Dec 31, 201325,267-5.77%
Dec 31, 201226,813+9.33%
Dec 31, 201124,526+9.12%
Dec 31, 201022,476

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)